<DOC>
	<DOC>NCT01101204</DOC>
	<brief_summary>The study is planned to show whether combined hypolipemic and antidiabetic therapy with various daily dosages influence the fasting plasma glucose, insulin sensitivity and proinflammatory cytokines in diabetic and dyslipidemic subjects.</brief_summary>
	<brief_title>The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>Age (3564yr) Primary hyperlipidemia (Total cholesterol &gt;200mg/dl, Triglycerides &gt;150mg/dl) Type 2 Diabetes For women: Menopause (&gt;12 months) Post hysterectomy Mechanical contraception Obtained informed consent Secondary hyperlipidemia Morbid obesity (BMI&gt;40kg/m2) Alcohol or drug abuse Acute or chronic inflammation Congestive Heart Failure (NYHA III or IV) Unstable Ischaemic Heart Disease Moderate or severe hypertension Cancer in less than 5 years Chronic kidney disease (stage IIIV) Liver failure Oral contraception Not compliant patient Laboratory results: alanine transferase (&gt;3xULN) creatine kinase (&gt;5xULN) haemoglobin (&lt;10/dl) PLT (&lt;100G/l) WBC (&lt;3,5G/l or &gt;10G/l)</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>